Zoetis Commercial United States

Ad Creative: A Librela bedinvetmab injection Story Norman An Actual Librela Patient

Zoetis A Librela bedinvetmab injection Story Norman An Actual Librela Patient Ad Commercial Brand Imagery Photoshoot 0
Zoetis A Librela bedinvetmab injection Story Norman An Actual Librela Patient Ad Commercial Brand Imagery Photoshoot 1
Zoetis A Librela bedinvetmab injection Story Norman An Actual Librela Patient Ad Commercial Brand Imagery Photoshoot 2

Zoetis Ad Profile

  • Advertising Market: United States
  • Advertiser Industry: Pet
  • Advertiser Category: Health
  • Ad Launch Date: 2025-03-19
  • Ad Format: 30 seconds
  • Ad Description: A Librela bedinvetmab injection Story Norman An Actual Librela Patient

Zoetis Ad Transcript

Creative storyline based on voiceover.

  • 00:00 - [Music]
  • 00:03 - life with Norman is fun and full of
  • 00:05 - Adventure he just started to slow down a
  • 00:07 - little bit on walks and seemed like he
  • 00:08 - had some discomfort his doctor diagnosed
  • 00:11 - him with osteoarthritis pain and
  • 00:13 - recommended that we try lella veterinary
  • 00:15 - professionals administering lella who
  • 00:17 - are pregnant trying to conceive or
  • 00:19 - breastfeeding should take extreme care
  • 00:20 - to avoid self- injection which can cause
  • 00:22 - allergic reactions like anaphylaxis
  • 00:25 - lella has helped Norman get back to his
  • 00:27 - old self

Zoetis Ad Visuals

Visual objects featured in the creative imagery.

Zoetis Ad Reach

Audience reach based on YouTube views benchmarked against Market, Industry and Category.

  Medium vs. United States

  Medium vs. Pet

  Medium vs. Health

Zoetis Ad Favorability

Creative favorability based on YouTube likes benchmarked against Market, Industry and Category.

  No Data

  No Data

  No Data

Zoetis Ad Engagement

Audience engagement based on YouTube comments benchmarked against Market, Industry and Category.

  No Data

  No Data

  No Data

Zoetis Ad Collections

Check out similar ads from competitors.